Semisynthetic Tetramate-Containing Fungal Metabolites with Activity against Trichomonas vaginalis and Mycoplasma genitalium

Thilini Peramuna, Gwendolyn E. Wood, Ziwei Hu, Karen L. Wendt, Laarni Kendra T. Aguila, Caroline M. Kim, Adam S. Duerfeldt, Robert H. Cichewicz

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Tetramic acid-containing natural products are well known for their promising biological activity against various diseases. In our previous study, we reported fungal-derived tetramic acid-containing natural products with activity against Trichomonas vaginalis. Here, we demonstrate that Mycoplasma genitalium is also highly susceptible to this chemotype and we uncovered the initial structure activity relationships on disparate tetramate chemotypes in phomasetin (6) and pyrrolocin A (10). Further, 6 and 10 were modified using “click” chemistry to re-engineer bioactivity. Compounds 6 and 10 hold promise as a pipeline-diversifying chemotype for promising leads against T. vaginalis and M. genitalium.

Original languageEnglish (US)
Pages (from-to)1933-1939
Number of pages7
JournalACS Medicinal Chemistry Letters
Volume15
Issue number11
DOIs
StatePublished - Nov 14 2024

Bibliographical note

Publisher Copyright:
© 2024 American Chemical Society.

Keywords

  • Mycoplasma genitalium
  • SAR
  • Trichomonas vaginalis
  • fungi
  • natural products
  • tetramic acid

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Semisynthetic Tetramate-Containing Fungal Metabolites with Activity against Trichomonas vaginalis and Mycoplasma genitalium'. Together they form a unique fingerprint.

Cite this